HSBC Initiates Coverage On BioNTech with Buy Rating, Announces Price Target of $124
Portfolio Pulse from richadhand@benzinga.com
HSBC analyst Rajesh Kumar has initiated coverage on BioNTech (NASDAQ:BNTX) with a Buy rating and a price target of $124.
July 14, 2023 | 9:59 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HSBC has initiated coverage on BioNTech with a Buy rating and a price target of $124, which could potentially drive the stock price up.
The Buy rating and price target set by HSBC indicates a positive outlook for BioNTech. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100